SAN DIEGO, Jan. 9, 2012/PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today provided an update on commercial sales of DIFICID® (fidaxomicin) tablets since launching the antibacterial drug in July 2011for the treatment of Clostridium …
Optimer Pharmaceuticals, Inc. : Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch – 4-traders (press release)
SAN DIEGO, Jan. 9, 2012/PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today provided an update on commercial sales of DIFICID® (fidaxomicin) tablets since launching the antibacterial drug in July 2011for the treatment of Clostridium …